These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 5293498

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunotherapy of leukaemia.
    Malpas JS.
    Schweiz Med Wochenschr; 1974 May 04; 104(18):626-33. PubMed ID: 4596725
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Active immunotherapy of L 1210 leukemia given after the graft of the tumor].
    Mathé G.
    Rev Fr Etud Clin Biol; 1968 Nov 04; 13(9):881-3. PubMed ID: 5304470
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Management of acute leukemias and linphosarcomas with active immunotherapy (author's transl)].
    Mathe G, Amiel JL, Schwarsenberg L, Hyat M, Pouillart P, Schenider M, Cattan A, Jasmin C, Belpomme D, Schulmberger JR, De Vassal F, Musset M, Misset JL.
    Folia Clin Int (Barc); 1975 Mar 04; 25(3):131-51. PubMed ID: 1056311
    [No Abstract] [Full Text] [Related]

  • 9. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T, Akahori Y, Sakurai Y.
    Cancer Res; 1984 Feb 04; 44(2):519-24. PubMed ID: 6537896
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Recent data on the immunotherapy of leukemias].
    Mathe G, Schwarzenberg L, Amiel JL, Pouillart P, Hayat M, De Vassal F, Rosenfeld C, Jasmin C.
    Recenti Prog Med; 1975 Oct 04; 59(4):314-29. PubMed ID: 769102
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of acute lymphoblastic leukemia in children during remission with a sequential chemotherapy followed by an active immunotherapy trial].
    Mathe G, Amiel JL, Schwarzenberg L, Schneider M, Cattan A, Schulumberger JR.
    Arch Fr Pediatr; 1968 Oct 04; 25(6):639-50. PubMed ID: 5245426
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G, Halle-Pannenko O, Bourut C, Hiu IJ.
    Johns Hopkins Med J Suppl; 1974 Oct 04; 3():85-102. PubMed ID: 4154074
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Considerations on some cases of acute lymphatic leukemia treated with aspecific active immunotheraphy].
    Saggese V, Zanda G.
    Minerva Pediatr; 1974 Jun 16; 26(21):1087-93. PubMed ID: 4526571
    [No Abstract] [Full Text] [Related]

  • 18. [Non specific active immunotherapy by B.C.G. in virus induced leukemia in E male G2 mice in isogenic receiptients].
    Amiel JL.
    Rev Fr Etud Clin Biol; 1967 Nov 16; 12(9):912-4. PubMed ID: 5591341
    [No Abstract] [Full Text] [Related]

  • 19. [Results of 3 protocols of treatment of acute lymphoid leukemia in children].
    Mathé G, de Vassal F, Schwarzenberg L, Delgado M, Weiner R, Gil MA, Pena-Angulo J, Belpomme D, Pouillart P, Machover D, Misset JL, Pico JL, Jasmin C, Hayat M, Schneider M, Cattan A, Amiel JL, Musset M, Rosenfeld C, Ribaud P.
    Arch Fr Pediatr; 1977 Nov 16; 34(7):611-21. PubMed ID: 270966
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.